VPU mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism

Journal of Virology

Volumn 86, Issue 16, 2012, Pages 8367-8374

  Doehle, Brian P ^a   Chang, Kristina ^a   Rustagi, Arjun ^a   McNevin, John ^b   McElrath, M Juliana ^a,b   Gale, Michael ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 3; PATTERN RECOGNITION RECEPTOR; VPU PROTEIN;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; INNATE IMMUNITY; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; VIRUS IDENTIFICATION; VIRUS IMMUNITY; VIRUS STRAIN;

EID: 84865106370     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00423-12     Document Type: Article

References (41)

1. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
2. Barro M, Patton JT. 2005. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factorProc. Natl. Acad. Sci. U. S. A. 102:4114-4119.
3. Bosinger SE, et al. 2004. Gene expression profiling of host response in models of acute HIV infection. J. Immunol. 173:6858-6863.
4. Dejucq N, Simmons G, Clapham PR. 2000. T-cell line adaptation of human immunodeficiency virus type 1 strain SF162: effects on envelope, Vpu and macrophage-tropism. J. Gen. Virol. 81:2899-2904. 4a.
5. Doehle BP, et al. 2012. Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells. J. Virol. 8499-8506.
6. Doehle BP, Gale M, Jr. 2012. Innate immune evasion strategies of HCV and HIV: common themes for chronic viral infection. In Sambhara S, Fujita T (ed), Nucleic acid sensors and antiviral immunity. Landes Bioscience, Austin, TX.
7. Doehle BP, Hladik F, McNevin JP, McElrath MJ, Gale M, Jr. 2009. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J. Virol. 83:10395-10405.
8. Doitsh G, et al. 2010. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 143:789-801.
9. Douglas JL, et al. 2010. The great escape: viral strategies to counter BST-2/tetherin. PLoS Pathog. 6:e1000913. doi:10.1371/journal.ppat. 1000913.
10. Douglas JL, et al. 2009. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/tetherin via a βTrCP-dependent mechanism. J. Virol. 83:7931-7947.
11. Foy E, et al. 2005. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. U. S. A. 102:2986-2991.
12. Foy E, et al. 2003. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145-1148.
13. Geiss GK, et al. 2000. Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology 266:8-16.
14. Harman AN, et al. 2011. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood 118:298-308.
15. Hilton L, et al. 2006. The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. J. Virol. 80:11723-11732.
16. Hladik F, et al. 1999. Dendritic cell-T-cell interactions support coreceptor-independent human immunodeficiency virus type 1 transmission in the human genital tract. J. Virol. 73:5833-5842.
17. Hladik F, Lentz G, Delpit E, McElroy A, McElrath MJ. 1999. Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR5(+) Th1 phenotype. J. Immunol. 163: 2306-2313.
18. Honda K, et al. 2005. IRF-7 is the master regulator of type-I interferondependent immune responses. Nature 434:772-777.
19. Horner SM, Liu HM, Park HS, Briley J, Gale M, Jr. 2011. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 108:14590-14595.
20. Iwabu Y, et al. 2009. HIV-1 accessory protein Vpu internalizes cellsurface BST-2/tetherin through transmembrane interactions leading to lysosomes. J. Biol. Chem. 284:35060-35072.
21. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11:373-384.
22. Kirchhoff F. 2010. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8:55-67.
23. Loo YM, Gale M, Jr. 2007. Viral regulation and evasion of the host response. Curr. Top. Microbiol. Immunol. 316:295-313.
24. Loo YM, et al. 2006. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc. Natl. Acad. Sci. U. S. A. 103:6001-6006.
25. Margottin F, et al. 1998. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1:565-574.
26. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. 2010. The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol. 10:11-23.
27. Mitchell RS, et al. 2009. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 5:e1000450. doi:10.1371/journal.ppat.1000450.
28. Neil S, Bieniasz P. 2009. Human immunodeficiency virus, restriction factors, and interferon. J. Interferon Cytokine Res. 29:569-580.
29. Ockenhouse CF, Bernstein WB, Wang ZN, Vahey MT. 2005. Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells. J. Infect. Dis. 191:2064-2074.
30. Okumura A, et al. 2008. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 373:85-97.
31. Pasare C, Medzhitov R. 2004. Toll-like receptors: linking innate and adaptive immunity. Microbes Infect. 6:1382-1387.
32. Pertel T, et al. 2011. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472:361-365.
33. Richards KH, Clapham PR. 2007. Effects of Vpu start-codon mutations on human immunodeficiency virus type 1 replication in macrophages. J. Gen. Virol. 88:2780-2792.
34. Schaefer TM, et al. 2006. Increased expression of interferon-induciblegenes in macaque lung tissues during simian immunodeficiency virus infection. Microbes Infect. 8:1839-1850.
35. Sgarbanti M, et al. 2002. Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J. Exp. Med. 195:1359-1370.
36. Stetson DB, Medzhitov R. 2006. Type I interferons in host defense. Immunity 25:373-381.
37. Sumpter R, et al. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689-2699.
38. Suthar MS, et al. 2010. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 6:e1000757. doi:10.1371/ journal.ppat.1000757.
39. Wilkins C, Gale M, Jr. 2010. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 22:41-47.
40. Yan N, Lieberman J. 2011. Gaining a foothold: how HIV avoids innate immune recognition. Curr. Opin. Immunol. 23:21-28.
41. Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J. 2010. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 11:1005-1013.